Structure and function of the Fgd family of divergent FYVE domain proteins

Aarskog–Scott syndrome Cdc42 Dbl FYVE Fgd GEF GTPase MODA PH PIP Rho cancer dysplasie faciogénitale faciogenital dysplasia lipid signaling membrane trafficking phosphoinositide pleckstrin pleckstrine signalisation lipidique syndrome Aarskog–Scott trafic membranaire

Journal

Biochemistry and cell biology = Biochimie et biologie cellulaire
ISSN: 1208-6002
Titre abrégé: Biochem Cell Biol
Pays: Canada
ID NLM: 8606068

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 12 10 2018
medline: 10 9 2019
entrez: 12 10 2018
Statut: ppublish

Résumé

FYVE domains are highly conserved protein modules that typically bind phosphatidylinositol 3-phosphate (PI3P) on the surface of early endosomes. Along with pleckstrin homology (PH) and phox homology (PX) domains, FYVE domains are the principal readers of the phosphoinositide (PI) code that mediate specific recognition of eukaryotic organelles. Of all the human FYVE domain containing proteins, those within the faciogenital dysplasia (Fgd) subfamily are particularly divergent and couple with GTPases to exert unique cellular functions. The subcellular distributions and functions of these evolutionarily conserved signal transducers, which also include Dbl homology (DH) and two PH domains, are discussed here to better understand the biological range of processes that such multidomain proteins engage in. Determinants of their various functions include specific multidomain architectures, posttranslational modifications including PIP stops that have been discovered in sorting nexins, PI recognition motifs, and phospholipid-binding surfaces as defined by the Membrane Optimal Docking Area (MODA) program. How these orchestrate Fgd function remains unclear but has implications for developmental diseases including Aarskog-Scott syndrome, which is also known as faciogenital dysplasia, and forms of cancer that are associated with mutations and amplifications of Fgd genes.

Identifiants

pubmed: 30308128
doi: 10.1139/bcb-2018-0185
doi:

Substances chimiques

FGD5 protein, human 0
Guanine Nucleotide Exchange Factors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-264

Auteurs

Gary Eitzen (G)

a Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Cameron C Smithers (CC)

b Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Allan G Murray (AG)

c Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Michael Overduin (M)

b Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH